| Issue Date | Title | Author(s) |
| 2014 | Association of the DRD2 TaqIA, 5-HT1B A-161T, and CNR1 1359 G/A polymorphisms with alcohol dependence | Şengül Balcı, Melike Ceyhan; Şengül, C.; Erdal, M.E.; İzci Ay, O.; Efe, M.; Ay, M.E.; Herken, H. |
| 2001 | Citalopram-induced photopigmentation | I°nalöz, H.S.; Kirtak, N.; Herken, H.; Özgöztaşi, O.; Aynacıoğlu, Ahmet Şükrü |
| 2007 | Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia | Semiz, U.B.; Cetin, M.; Basoglu, C.; Ebrinc, S.; Uzun, O.; Herken, H.; Balibey, H. |
| 2017 | Effects of methylphenidate treatment on the cerebellum in adult attention-deficit hyperactivity disorder: a magnetic resonance spectroscopy study | İnci Kenar, Ayşe Nur ; Unal, G.A.; Kiroglu, Y.; Herken, H. |
| 2008 | Hypofrontality in schizophrenics evaluated by near infrared spectroscopy | Serap, S.; Herken, H.; Akin, A. |
| 2007 | Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment | Ozen, M.E.; Yumru, M.; Savas, H. ; Cansel, N.; Herken, H. |
| 2012 | The relationship DRD3 Ser9Gly polymorphisms and cognitive functions in schizophrenia: A preliminary study | Sözeri Varma, Gülfizar ; Karadag, F.; Erdal, M.E.; Izciay, O.; Aydin, E.; Gökdogan Edgünlü, T.; Herken, H. |
| 2014 | Remarkable effect of benzodiazepine in a patient with anti-NMDA receptor encephalitis | Erdogan, Çağdaş ; Sari, Hakan İsmail ; Herken, H.; Degirmenci, E. ; Oguzhanoglu, A. |
| 2008 | Role of oxidative and antioxidative parameters in etiopathogenesis and prognosis of panic disorder | Ersoy, M.A.; Selek, S.; Celik, H.; Erel, O.; Kaya, M.C.; Savas, H.A.; Herken, H. |
| 2006 | An unusual form of self-mutilation: tongue amputation with local anesthesia | Erdur, Bülent ; Türkçüer, İbrahim ; Herken, H. |
